Calgary, Alberta--(Newsfile Corp. - November 27, 2012) - Algae Biosciences Corporation (“AlgaeBio” or the “Company”) (TSXV: ABV) is pleased to announce the execution of a Memorandum of Understanding (MOU) to negotiate and enter into a Research & Development (R&D) Agreement leading to a License Agreement with Syngar Technologies Inc. (Syngar), a private company based in Edmonton, Canada. In partnership with Syngar, and using Syngar’s PLUSWaveTM technology, AlgaeBio will develop high-yield algae lipid/oil production systems to ...